In combination with previous findings that CXCL14 overexpression is consistent with chemoresistance in bladder cancer patients, we classified abnormal CXCL14 expressing CAFs as differentiated iCAFs or undifferentiated naïve CAFs. Here, CXCL14 is linked to urinary bladder cancer.